Skip to main content

Closed

SION: Sionna Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-33.4%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage0.0×

Current ratio22.60×

Sionna Therapeutics, Inc.

SIONNASDAQ Global Market·USD·Closed

Sionna Therapeutics, Inc.

SIONNASDAQ·USD·Closed

$47.13

+0.75%

$47.13

+$0.35 (0.75%)

52W Range

87thpctl

Volume

0.84×avg

Mkt Cap

2.13BUSD

P/E

-24.4TTM

Div Yield

–ann

52W Range

87thpctl

Volume

0.84×avg

Market Cap

2.13BUSD

P/E Ratio

-24.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings